CytoSorbents Corporation CTSO
NASDAQ · United States · Health Technology
$4.05-0.13 (-3.23%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.00 | -0.90 | -11.1% | $9.63M | +2.6% | -6.5%$7.70→$7.20 |
| Q1 2026 | 2026-05-13 | -1.60 | -1.10 | -45.5% | — | — | -7.5%$11.72→$10.84 |
| Q4 2025 | 2026-03-25 | -1.80 | -1.00 | -80.0% | — | — | -13.8%$13.92→$12.00 |
| Q3 2025 | 2025-11-13 | -1.00 | -0.93 | -7.5% | — | — | +3.3%$12.78→$13.20 |
| Q1 2025 | 2025-05-14 | -0.40 | -1.40 | +71.4% | — | — | — |
| Q4 2024 | 2025-03-31 | -2.80 | -1.07 | -161.7% | — | — | — |
| Q2 2024 | 2024-08-13 | -1.60 | -1.95 | +17.9% | — | — | — |
| Q4 2023 | 2024-03-14 | -2.40 | -2.20 | -9.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.